[Anhydrous theophylline in micropellets with prolonged action in asthmatic children].
The present study was realized to evaluate the effectiveness, security and tolerability of slow release micro pellets theophylline, in a group of 168 asthmatic children, between 2 and 15 years old. The improvement of the symptoms was obtained, since the treatment began. The final evaluation was considered excellent and good in 86.90% of the cases, and the tolerability, excellent and good in 94.64% of the patients. In conclusion the slow-release micro pellets theophylline is a very effective and secure drug, with a very good tolerability for the treatment of the asthmatics in pediatric age.